Baqsimi, Nasenpulver

7680674650010 CH-67465 Nasenpulver

Associated product:

BAQSIMI 3 mg pdr appl nasale
Baqsimi, Nasenpulver
Baqsimi, Nasenpulver
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Stück
Galenic form
Nasenpulver
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/08/2024
Patient information leaflet
Français
06/08/2024
Patient information leaflet
Italien
06/08/2024
Summary of Product Characteristics
Allemand
06/08/2024
Summary of Product Characteristics
Français
06/08/2024
Summary of Product Characteristics
Italien
06/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 61.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2022

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
67465
Drug name
Baqsimi, Nasenpulver
Galenic form
NASP
ATC Code
H04AA01
Authorization status
Z
Dispensing category
B
First authorization
11/06/2020
Authorization expiration date
31/12/9999
IT Number
07.06.3.
Domain
Human medicine
Field of application
schwere Hypoglykämie

Package details

Description (FR)
BAQSIMI 3 mg pdr appl nasale
Description (DE)
BAQSIMI 3 mg Pulv zur nasal Anwendung
Market launch
11/06/2020
Narcotic (BTM)
No